Join
Live feed
·
PRReleasevia Quantisnow
AbbVie Inc. logo
Landos Biopharma Inc. logo

NImmune Biopharma Announces Presentations at Digestive Disease Week 2026 Supporting a Differentiated Profile and Superior Efficacy of Oral, Once-Daily NIM-1324 for IBD

ByQuantisnow·Wall Street's wire, on your screen.
ABBV· AbbVie Inc.LABP· Landos Biopharma Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ABBV (AbbVie Inc.), LABP (Landos Biopharma Inc.) and more on Quantisnow.